# Topical Steroid Treatment for Eosinophilic Esophagitis

> **NCT00275561** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 42 (actual)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

- **DRUG:** Fluticasone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00275561
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2012-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00275561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00275561, "Topical Steroid Treatment for Eosinophilic Esophagitis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00275561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*